ENTO

Entero Therapeutics
ENTO

Overview Fund Trends Analyst Outlook Journalist POV

6 hedge funds and large institutions have $1.54M invested in Entero Therapeutics in 2019 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $
Holders
6
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$279K
2
+$160K
3
+$51K
4
TA
Tiedemann Advisors
New York
+$38K

Top Sellers

1
-$1.1M
2
-$926K
3
-$255K
4
OM
Opaleye Management
Massachusetts
-$247K
5
BlackRock
BlackRock
New York
-$72K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$640K
2
$419K
3
$259K
4
$51K
5
$41K
6
$38K
7
$29K
8
$17K
9
$14K
10
$12K
11
$7K
12
$7K
13
$4K
14
$3K
15
$3K
16
$1K
17
–
18
–
19
–
20
–
21
–
22
–
23
–